Fair value (multi-method)
Four independent methods triangulate what BSX is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$19.93
Method range
$18.78 – $181.65
median $51.88
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $19.93 | -58.96% |
| Exit multiple | $181.65 | +274.15% |
| Analyst target | $83.84 | +72.69% |
| Graham number | $18.78 | -61.31% |
- Forward DCF$19.93
- Exit multiple$181.65
- Analyst target$83.84
- Graham number$18.78
Stock price
$48.55
FCF / share (TTM)
$0.12
3Y FCF CAGR
27.8%
Fair value @ hist. growth
$16.01
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
43.6%
per year over your projection horizon
Margin of safety -203.3% vs hist-growth DCF
Historical 3Y CAGR
27.8%
Your model implies
43.6%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at 28% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.7% | 38.4% | 36.8% | 34.9% | 32.7% | 30.1% |
| 6.7% | 42.4% | 41.1% | 39.6% | 38.0% | 36.1% |
| 7.7% | 46.0% | 44.8% | 43.6% | 42.3% | 40.8% |
| 8.7% | 49.2% | 48.2% | 47.2% | 46.1% | 44.8% |
| 9.7% | 52.2% | 51.4% | 50.5% | 49.5% | 48.4% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.17
Low vs growth
Net debt
$10.4B
Total debt − cash
Beta
0.62
Vs market benchmark
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation